GZMB and neoplasm: Secreted GDF15 activates JNK signaling, downregulating the NK cell-killing essential receptor NKG2D and the effector molecule granzyme B (GZMB), thereby impairing NK cell cytotoxicity and enabling tumor cells to evade immune surveillance [115].